287 related articles for article (PubMed ID: 32276399)
21. Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.
Jarret A; McFarland AP; Horner SM; Kell A; Schwerk J; Hong M; Badil S; Joslyn RC; Baker DP; Carrington M; Hagedorn CH; Gale M; Savan R
Nat Med; 2016 Dec; 22(12):1475-1481. PubMed ID: 27841874
[TBL] [Abstract][Full Text] [Related]
22. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
23. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
Tan H; Derrick J; Hong J; Sanda C; Grosse WM; Edenberg HJ; Taylor M; Seiwert S; Blatt LM
J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.
Riva E; Scagnolari C; Turriziani O; Antonelli G
Clin Microbiol Infect; 2014 Dec; 20(12):1237-45. PubMed ID: 25273834
[TBL] [Abstract][Full Text] [Related]
25. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
[TBL] [Abstract][Full Text] [Related]
26. Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients.
Jouan L; Chatel-Chaix L; Melançon P; Rodrigue-Gervais IG; Raymond VA; Selliah S; Bilodeau M; Grandvaux N; Lamarre D
J Hepatol; 2012 Jan; 56(1):70-7. PubMed ID: 21835140
[TBL] [Abstract][Full Text] [Related]
27. Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance.
Asthana M; Sahu SK; Kumar A; Mohanty S; Chakrabarti S; Das P; Chattopadhya NR; Chatterjee K; Singh SP; Rajasubramaniam S; Choudhuri T
Curr Drug Metab; 2018; 19(3):215-223. PubMed ID: 29380700
[TBL] [Abstract][Full Text] [Related]
28. Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.
Neukam K; Barreiro P; Rivero-Juárez A; Caruz A; Mira JA; Camacho A; Macías J; Rivero A; Soriano V; Pineda JA
J Infect; 2013 Jul; 67(1):59-64. PubMed ID: 23542783
[TBL] [Abstract][Full Text] [Related]
29. Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV).
Nakai M; Oshiumi H; Funami K; Okamoto M; Matsumoto M; Seya T; Sakamoto N
Sensors (Basel); 2015 Oct; 15(10):27160-73. PubMed ID: 26512676
[TBL] [Abstract][Full Text] [Related]
30. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus: standard-of-care treatment.
Pawlotsky JM
Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
[TBL] [Abstract][Full Text] [Related]
32. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.
Lamers MH; Broekman M; Drenth JP; Gluud C
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD011132. PubMed ID: 24937404
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
34. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
35. How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals.
Serfaty L
Liver Int; 2015 Jan; 35 Suppl 1():18-20. PubMed ID: 25529083
[TBL] [Abstract][Full Text] [Related]
36. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
Obajemu AA; Rao N; Dilley KA; Vargas JM; Sheikh F; Donnelly RP; Shabman RS; Meissner EG; Prokunina-Olsson L; Onabajo OO
J Immunol; 2017 Dec; 199(11):3808-3820. PubMed ID: 29070670
[TBL] [Abstract][Full Text] [Related]
37. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
38. Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
Lee JW; Kim W; Kwon EK; Kim Y; Shin HM; Kim DH; Min CK; Choi JY; Lee WW; Choi MS; Kim BG; Cho NH
PLoS One; 2017; 12(6):e0179094. PubMed ID: 28614389
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling.
Rong L; Perelson AS
Crit Rev Immunol; 2010; 30(2):131-48. PubMed ID: 20370626
[TBL] [Abstract][Full Text] [Related]
40. BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.
Amet T; Byrd D; Hu N; Sun Q; Li F; Zhao Y; Hu S; Grantham A; Yu Q
Curr Mol Med; 2014 Mar; 14(3):349-60. PubMed ID: 24236455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
